Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-007527
Filing Date
2025-03-03
Accepted
2025-03-03 16:30:24
Documents
1
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 7092
  Complete submission text file 0001127602-25-007527.txt   8819
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Issuer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, FLOOR 37 NEW YORK NY 10001
Business Address
DeFrancesco Lisa (Reporting) CIK: 0001846325 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30111 | Film No.: 25698474